Red cell distribution width as a marker of inflammation in type 2 diabetes mellitus

Life Science Journal

Volumn 10, Issue 3, 2013, Pages 1501-1507

  Sherif, Heba ^a   Ramadan, Nagwa ^a   Radwan, Mona ^a   Hamdy, Enas ^a   Reda, Rabab ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Inflammation; Red cell distribution width; Type 2 diabetes mellitus

Indexed keywords

EID: 84884131055     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. January 2013; 36(1): S67-S74.
2. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2010; 33(1):11-61.
3. Cheung N, Wong TY. Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res. 2008; 27:161-176.
4. Lakoski SG, Cushman M, Siscovick DS, Blumenthal RS, Palmas W, Burke G, et al. The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Hum Hypertens. 2010; 25:73-79.
5. Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med 1991; 9(1):71-74.
6. Ferrucci L, Guralnik JM, Woodman RC, Bandinelli S, Lauretani F, Corsi AM, et al. Proinflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med 2005; 118: 1288.
7. Tsuboi S, Miyauchi K, Kasai T, Ogita M, Dohi T, Miyazaki T, et al. Impact of Red Blood Cell Distribution Width on Long-Term Mortality in Diabetic Patients After Percutaneous Coronary Intervention. Circ J 2013; 77: 456-461.
8. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M, for the Cholesterol and Recurrent Events (CARE) Trial Investigators. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008;117:163-168.
9. Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med 2009; 169:515-523.
10. Malandrino N, Wu WC, Taveira T H, Whitlatch H B and Smith R J. Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes. Diabetologia 2012; 55:226-235.
11. Diabetic Retinopathy Study Group (1981) Report number 7. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci. 1981; 21:210-226.
12. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002; 19: 377-384.
13. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009; 133:628-632.
14. Al-Najjar Y, Goode KM, Zhang J, Cleland JG, Clark AL. Red cell distribution width: an inexpensive and powerful prognostic marker in heart failure. Eur J Heart Fail. 2009 Dec;11(12):1155-62.
15. Patel KV, Semba RD, Ferrucci L, Newman AB, Fried LP, Wallace RB, et al. Red cell distribution width and mortality in older adults: A metaanalysis. J Gerontol A Biol Sci Med Sci. 2010; 65: 258-265.
16. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-1023.
17. King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008; 79(8):1527-1534.
18. Sánchez-Chaparro MA, Calvo-Bonacho E, González-Quintela A, et al. Higher red blood cell distribution width is associated with the metabolic syndrome: results of the Ibermutuamur Cardiovascular Risk Assessment study. Diabetes Care. 2010; 33:e40.
19. Acosta J, Hettinga J, Flückiger R, et al. Molecular basis for a link between complement and the vascular complications of diabetes. Proc Natl Acad Sci USA. 2000; 97:5450-5455.
20. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA. 1997; 277:973-976.
21. Lee YH, Partley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep.2005; 5: 70-75.
22. Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007; 50:40-47.
23. Veeranna V, Zalawadiya SK, Panaich SS, Ramesh K, Afonso L. The association of red cell distribution width with glycated hemoglobin among healthy adults without diabetes mellitus. Cardiology. 2012;122:129-132.
24. Ramana KV, Freidrich B, Srivastava S, Bhatnagar A, Srivastava SK. Activation of nuclear factor-kB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes. 2004 November; 53(11): 2910-2920.
25. Sell H, etz-Schoeder D, Eckel J. The adipocytesmonocyte axis in insulin resistance. Trends of Endocrinol Metab.2006;17: 416-{pipe} 422.
26. Rathcke CN, Johansen JS, Vestergaard H. YKL-40, a biomarker of inflammation is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflamm Res. 2006;55: 53-59.
27. Krabe KS, Nielsen AR, Krogh-Madsen R, Plomgaard, Rasmussen P, Erikstrup C, et al. Brain derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia. 2007 Feb;50(2):431-8.
28. Tanindi A, Topal FE, Topal F, Celik B. Red cell distribution width in patients with prehypertension and hypertension. Blood Press. 2012 Jun;21(3):177-81.
29. Rabkin SW, Langer A, Ur E, Calciu C, Leiter LA. Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy. Hypertension Research. 2013, 1-9.
30. Pietri P, Vyssoulis G, Vlachopoulos C, Zervoudaki A, Gialernios T, Aznaouridis K, et al. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. J Hypertens. 2006; 24: 2231-2238.
31. Karantza MV, Mittelman SD, Dorey F, Samie S, Kaiserman K, Halvorson M, et al. Relationship of highly sensitive C-reactive protein and lipid levels in adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2007 Apr;9(2):122-6.